l-697661 has been researched along with Viremia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Chopra, P; Emini, EA; Hahn, BH; Kappes, JC; McFarland, R; Piatak, M; Saag, MS; Shaw, GM; Yang, LC | 1 |
Davey, RT; Dewar, RL; Falloon, J; Haneiwich, SE; Kovacs, JA; Masur, H; Polis, MA; Reed, GF; Vasudevachari, MB; Walker, RE | 1 |
Baumberger, C; Hirschel, B; Kinloch-de Loës, S; Pechère, M; Perrin, L; Rakik, A; Yerly, S | 1 |
2 trial(s) available for l-697661 and Viremia
Article | Year |
---|---|
Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
Topics: Antiviral Agents; Benzoxazoles; Biomarkers; CD4 Lymphocyte Count; Double-Blind Method; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Immunoassay; Polymerase Chain Reaction; Prospective Studies; Pyridones; Reverse Transcriptase Inhibitors; RNA, Viral; Viremia; Zidovudine | 1995 |
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Benzoxazoles; beta 2-Microglobulin; Biomarkers; CD4 Antigens; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Male; Neoplasms; Pyridones; Time Factors; Viremia; Zidovudine | 1993 |
1 other study(ies) available for l-697661 and Viremia
Article | Year |
---|---|
Combined therapy with zidovudine and L-697,661 in primary HIV infection.
Topics: Adult; Anti-HIV Agents; Benzoxazoles; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; DNA, Viral; Drug Therapy, Combination; HIV Infections; Humans; Pyridones; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Viremia; Zidovudine | 1996 |